Free Trial

Dynavax Technologies (DVAX) Stock Forecast & Price Target

Dynavax Technologies logo
$12.85 -0.11 (-0.85%)
(As of 12/16/2024 ET)

Dynavax Technologies - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
1
Buy
2

Based on 3 Wall Street analysts who have issued ratings for Dynavax Technologies in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 3 analysts, 1 has given a hold rating, and 2 have given a buy rating for DVAX.

Consensus Price Target

$22.00
71.21% Upside
According to the 3 analysts' twelve-month price targets for Dynavax Technologies, the average price target is $22.00. The highest price target for DVAX is $29.00, while the lowest price target for DVAX is $15.00. The average price target represents a forecasted upside of 71.21% from the current price of $12.85.
Get the Latest News and Ratings for DVAX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Dynavax Technologies and its competitors.

Sign Up

DVAX Analyst Ratings Over Time

TypeCurrent Forecast
12/18/23 to 12/17/24
1 Month Ago
11/18/23 to 11/17/24
3 Months Ago
9/19/23 to 9/18/24
1 Year Ago
12/18/22 to 12/18/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
3 Buy rating(s)
2 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$22.00$22.00$23.67$27.50
Forecasted Upside71.21% Upside80.18% Upside111.12% Upside101.61% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Buy

DVAX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

DVAX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Dynavax Technologies Stock vs. The Competition

TypeDynavax TechnologiesMedical CompaniesS&P 500
Consensus Rating Score
2.67
2.80
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside71.21% Upside29,356.40% Upside11.25% Upside
News Sentiment Rating
Very Positive News

See Recent DVAX News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/8/2024HC Wainwright
2 of 5 stars
 Reiterated RatingBuy ➝ Buy$29.00 ➝ $29.00+141.26%
8/8/2024The Goldman Sachs Group
2 of 5 stars
 Lower TargetNeutral ➝ Neutral$20.00 ➝ $15.00+39.15%
2/23/2024William Blair
2 of 5 stars
 Reiterated RatingOutperform
11/3/2023JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Outperform ➝ Market Outperform$25.00 ➝ $27.00+89.87%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 04:47 AM ET.


DVAX Forecast - Frequently Asked Questions

According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for Dynavax Technologies is $22.00, with a high forecast of $29.00 and a low forecast of $15.00.

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Dynavax Technologies in the last twelve months. There is currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" DVAX shares.

According to analysts, Dynavax Technologies's stock has a predicted upside of 71.21% based on their 12-month stock forecasts.

Dynavax Technologies has been rated by research analysts at HC Wainwright in the past 90 days.

Analysts like Dynavax Technologies less than other "medical" companies. The consensus rating score for Dynavax Technologies is 2.67 while the average consensus rating score for "medical" companies is 2.81. Learn more on how DVAX compares to other companies.


This page (NASDAQ:DVAX) was last updated on 12/17/2024 by MarketBeat.com Staff
From Our Partners